EcoDrugPlus

Cyclin Dependent Kinase 4

Ensembl ID : ENSPFOG00000009452
Gene Symbol: CDK4
3 Cross references
238 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSPFOG00000013234
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSPFOG00000017422
Gene Symbol: CDK7
3 Cross references
218 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSPFOG00000005383
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSPFOG00000015459
Gene Symbol: CDK1
1 Cross references
245 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSPFOG00000015558
Gene Symbol: CDK1
1 Cross references
245 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSPFOG00000015509
Gene Symbol: CDK1
1 Cross references
245 Possible Orthologues:

Cyclin-Dependent Kinase 6

Ensembl ID : ENSPFOG00000000521
Gene Symbol: LOC103134991
3 Cross references
200 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSPFOG00000020487
Gene Symbol: CYSLTR1
1 Cross references
172 Possible Orthologues:

Cytidine Deaminase B

Ensembl ID : ENSPFOG00000017993
Gene Symbol: CDAB
1 Cross references
200 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSPFOG00000009240
Gene Symbol: LOC103142390
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSPFOG00000008633
Gene Symbol: LOC103137413
2 Cross references
527 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).